GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kalaris Therapeutics KLRS · USD

Health Care · US listing · 🇺🇸 United States

Compare

2.30

-4.96%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Largest shareholders

As filed, so dates differ, and a group and its funds can both appear.

HolderSharesStakeChangeFiled
Samsara BioCapital, LLC11.4m61.22%—30 Jun 2025
ElevateBio LLC725k3.88%—25 Jun 2025
Ferrara (Napoleone)504k2.70%—25 Jun 2025
F2 MG Ltd427.3k2.29%−125 Jun 2025
Tang Capital Management, LLC360.9k1.93%+51.6k30 Jun 2025
Octagon Capital Advisors LP360k1.93%−121k30 Jun 2025
Gilead Sciences Inc317.8k1.70%−405.5k30 Jun 2025
Invus Public Equities Advisors, LLC282.6k1.51%—30 Jun 2025
Rezai (Kourous)203.7k1.09%+203.7k25 Jun 2025
Hallal (David L)130.6k0.70%+1.5k25 Jun 2025
The Vanguard Group, Inc.129.8k0.69%+14.8k30 Jun 2025
Renaissance Technologies LLC96.8k0.52%+77.5k30 Jun 2025
Redmile Group, LLC83k0.44%—30 Jun 2025
Squarepoint Capital LLP59.1k0.32%+44.5k30 Jun 2025
Millennium Management LLC54.1k0.29%+37.5k30 Jun 2025

Short interest

Shares sold short, 15 Oct 2026. US exchange data.

306.4k

-7.7% on the period before. 3.5 days to cover.

Short volume

Share of the day's trading sold short, 4 Nov 2026

41.8%

Last 60 trading days.

Failed deliveries

Shares not delivered on settlement, from the SEC

  • 30 Sept 2026364 shares
  • 22 Sept 202613,446 shares
  • 21 Sept 202617,820 shares
  • 18 Sept 20261,194 shares
  • 17 Sept 2026126 shares

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.